New research has recently been published that builds upon evidence from a previous trial investigating the potential of Sabinsa’s Curcumin C3 Reduct® ingredient in oral care applications.
Sabinsa Top Scientist Gives Presentation to U.S. FDA
- Details
- Press Release
- 595

Dr. Kalyanam Nagabhushanam, President (R&D), Sabinsa Corporation presented, at the invitation of FDA, a seminar on December 10, 2020 to a group of US FDA scientists as part of the CDER Botanical Drug Seminar Series (BDSS).
Sabinsa Expands IP Portfolio with Five New U.S. Patents, Two CII Awards for IP Portfolio, and Dr. Majeed Honored by IASTAM
- Details
- Press Release
- 605

Sabinsa ends the year with more good news about achievements. The Confederation of Indian Industry (CII) recognized the Sami-Sabinsa Group with two awards for IP property, and Sami-Sabinsa Founder and Chairman, Dr. Muhammed Majeed, was honored by the Indian Association for the Study of Traditional Asian Medicine (IASTAM). Additionally, the company has been granted five new U.S. patents, including strengthening IP protection on its flag-ship probiotic, LactoSpore® with new applications, and additional patents for novel compositions.
Sabinsa’s Macumax® Formula Demonstrates Vision Health Benefits in Published Study
- Details
- Press Release
- 619

Sabinsa’s proprietary formulation Macumax® was shown to have vision health benefits in a clinical trial on subjects diagnosed with age-related macular degeneration (AMD). The study An Open-Label Pilot Study on Macumax Supplementation for Dry-Type Age-Related Macular Degeneration authored by Muhammed Majeed, Shaheen Majeed and Kalyanam Nagabhushanam, was published in the Journal of Medicinal Food (ahead of print doi.org/10.1089/jmf.2020.0097).
Sabinsa Founder Honored by ASSOCHAM for Lifetime Achievement
- Details
- Press Release
- 572

Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group was honored with a lifetime achievement award in recognition of his exemplary services in the nutraceuticals and cosmeceuticals industry by ASSOCHAM (The Associated Chambers of Commerce and Industry of India). The award was presented as part of Ayush Mela, one of India’s largest exhibition and conference events related to Ayurveda, Yoga & Naturopathy, Unani, Siddha, and Homeopathy (AYUSH).
Sabinsa Founder Dr. Muhammed Majeed Publishes Fourth Book on Boswellia
- Details
- Press Release
- 562

Dr. Muhammed Majeed, Founder and Chairman, Sami-Sabinsa Group has recently published the fourth book in a series on derivatives of Boswellia serrata.
Sabinsa Continues the Fight Against Adulterated Vitamin C in Food and Beverage Products by Alerting Regulatory Agencies
- Details
- Press Release
- 694

Sabinsa, a pioneer in the nutraceutical and cosmeceutical industry, has provided documentation to appropriate government agencies in its continuing efforts to identify and remove adulterated vitamin C additives from the market, a practice to which Sabinsa alerted the industry earlier this year.
Sabinsa Providing Glyphosate Test Results with Ingredients
- Details
- Press Release
- 596

Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, is offering glyphosate test results to customers, using a proprietary method for testing glyphosate developed by scientists at parent company Sami-Sabinsa. In October they began testing for residual herbicide in 20 nutraceutical ingredients as a routine practice, along with all other USP listed pesticides, and are widening the scope to all products the company sells. Spices must be below 7 ppm and herbs below 0.2 ppm.
Sabinsa Granted Patent in Mexico on Boswellin® PS for Inflammation
- Details
- Press Release
- 575

Sabinsa, a pioneer in the nutraceutical and cosmeceutical industries, has expanded its large portfolio of intellectual property with a new patent granted in Mexico for the company’s Boswellia serrata ingredient Boswellin® PS.
Sabinsa Granted Three New Patents in Canada, Including uC3 Clear® Water Soluble Curcumin
- Details
- Press Release
- 564

Sabinsa, a pioneer in nutraceutical and cosmeceutical industry, has strengthened its market position in Canada with the grant of three new patents. The company has also received an additional Natural Products Number (NPN) issued by Health Canada, bringing their total number of products with health claims in Canada to 37.
© 2021 Sabinsa. All Rights Reserved | Powered by Edkal Technologies | Disclaimer